在恶性瘤中Musashi-2进展的最新情况
Yiting Niu1, Tao Zhou2, Yanjun Li1
1Department of Hepatobiliary and Pancreatic Surgery, Shanxi Bethune Hospital, Shanxi Academy of Medical Sciences, Tongji Shanxi Hospital, Third Hospital of Shanxi Medical University, 030032 Taiyuan, Shanxi, China.
Frontiers in bioscience (Landmark edition)
|January 25, 2025
概括
慕沙希 (MSI) 蛋白质,特别是MSI2,与癌症的发展,转移和耐药性有关. 了解MSI2 的理解
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 细胞生物学 细胞生物学
背景情况:
- 穆沙希 (MSI) 蛋白家族已被广泛研究,以确定其在细胞线粒分裂中的作用.
- MSI蛋白质与各种恶性瘤的发展,转移,迁移和耐药性有关.
- 最近的研究突出了对MSI蛋白功能和药物耐药性机制的新见解,包括淋巴瘤和胰腺癌.
研究的目的:
- 审查MSI2与癌症相关的最新研究进展.
- 总结MSI2在瘤发生,迁移和耐药性的作用.
- 探索MSI2作为瘤免疫抑制剂和生物标志物的点的潜力.
主要方法:
- 关于MSI2和癌症的最新科学出版物的文献综述.
- 在不同瘤类型中分析MSI2表达水平和调节机制.
- 检查MSI2对药物耐药性途径的参与,包括p53突变和向疗法.
主要成果:
- 在大多数瘤中,MSI2的表达很高,并且与预后不佳有关.
- 具体的MSI2表达模式和调节机制因瘤类型而异.
- MSI2在瘤进展中发挥作用,并可能影响对蛋白质阿尔金因N-甲基转移酶5-向疗法等疗法的反应.
结论:
- MSI2是多种恶性瘤的重要因素,包括血液学疾病,腹部瘤,质母细胞瘤和乳腺癌.
- 对MSI2的机制进行进一步的研究对于开发新型癌症疗法和生物标志物至关重要.
- 针对MSI2可能为克服耐药性和改善癌症治疗结果提供潜在的策略.
更多相关视频
07:44Practical Considerations in Studying Metastatic Lung Colonization in Osteosarcoma Using the Pulmonary Metastasis Assay
Published on: March 12, 2018
10.0K
10:27Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts
Published on: July 25, 2020
7.2K
相关概念视频
02:07Tumor Progression
6.2K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.2K
02:57Targeted Cancer Therapies
7.4K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.4K
03:03mTOR Signaling and Cancer Progression
3.7K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.7K